Both in Pharmaceuticals
Annexon vs Collegium Pharmaceutical
Over the past year ANNX returned +32.6% and COLL returned −33.8%; their daily moves had a correlation of 0.05.
ANNX +32.6% COLL −33.8%Growth of $1, one year, split-adjusted
| Metric | ANNX | COLL |
|---|---|---|
| Price | $4.21 | $23.89 |
| Market cap | $797.2M | $777.8M |
| Today | +6.73% | +0.89% |
| 1 month | +0.1% | +9.2% |
| 6 months | −26.5% | −32.4% |
| Year to date | −16.2% | −48.4% |
| 1 year | +33.1% | −33.6% |
| Revenue growth (YoY) | — | +6.3% |
| Gross margin | — | 86.7% |
| Net margin | — | −7.5% |
| P/E (TTM) | — | 16.2× |
| Price / sales | — | 1.0× |
| Net cash | $209.2M | -$962.1M |
| Dividend yield | — | — |
| Volatility (60d) | 64.0% | 35.2% |
| Short % of float | 20.6% | 17.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).